How Paloma Is Fixing the Most Mismanaged Chronic Condition in America

The Lab Says You're Fine. You Know You're Not.

There's a particular kind of medical frustration that thyroid patients know intimately. You go to your doctor exhausted — genuinely, bone-deep exhausted — and describe months of brain fog, unexplained weight gain, hair falling out in the shower, a cold you can't shake even in July. Your doctor orders a TSH test. The result comes back within the reference range. And then comes the sentence that has driven millions of patients to the internet in desperation: "Your labs look normal."

Normal. Despite everything you're feeling.

This isn't a fringe experience. It's the standard of care for one of the most common chronic conditions on the planet. Thyroid disease affects an estimated 20 million Americans — and up to 60% of them are undiagnosed or undertreated. The reason isn't a lack of awareness. It's a lack of rigor. The conventional approach — a single TSH measurement and a levothyroxine prescription — ignores the full complexity of thyroid physiology. It doesn't measure Free T3, Free T4, TPO antibodies, or reverse T3. It doesn't adjust medication based on how a patient actually feels. It treats a dynamic, symptoms-driven condition like a checkbox.

Paloma was founded to change that. Built on the belief that thyroid patients deserve care as persistent as their condition, Paloma delivers comprehensive, longitudinal thyroid care — starting with the right tests and ending with patients who genuinely feel well, not patients who merely fall within a lab range.

What Paloma Actually Does

Paloma isn't a telemedicine platform that happens to treat thyroid conditions. It's a purpose-built thyroid care system that addresses every failure point in the conventional model — from incomplete testing to rushed appointments to zero follow-through.

The care journey starts with an at-home comprehensive thyroid panel. Not just TSH. The full picture: Free T3, Free T4, TSH, TPO antibodies, and reverse T3. A patient collects a small blood sample at home, sends it to the lab, and receives results that actually reflect what's happening in their thyroid system. For many patients, this is the first time they've seen their own Free T3 value. For some, it's the first time they've understood why they've felt the way they have for years.

Those results don't land in a patient portal with no context. They go directly to a Paloma virtual endocrinologist who specializes in thyroid conditions — not a generalist with seven minutes to spare. These are clinicians who understand the difference between a TSH of 2.5 and a TSH of 0.8 in the context of a symptomatic patient. Who know how to interpret a high reverse T3 ratio. Who take the time to connect lab values to the lived experience of fatigue, weight changes, brain fog, and mood instability that thyroid patients describe.

But the most important thing Paloma does isn't the test or the consultation. It's the continuous care loop.

Thyroid care is longitudinal by nature. Medication doses need adjustment as seasons change, weight fluctuates, stress levels shift, and the thyroid itself evolves. A one-time consultation followed by years of silence — the current standard — is almost guaranteed to leave patients symptomatic again within months. Paloma's symptom tracking tools and periodic retesting create an ongoing feedback system that catches drift early, before it becomes a months-long spiral back into exhaustion and fog.

Who Paloma Is For

The target Paloma patient is not hard to find — there are tens of millions of them. She's most commonly a woman between 30 and 60 (thyroid disease affects women at roughly 7x the rate of men). She's been diagnosed with hypothyroidism or Hashimoto's thyroiditis, or suspects she has a thyroid condition that hasn't been formally identified. She's on levothyroxine but still doesn't feel like herself. She's Googled "why do I still feel tired on thyroid medication" at 11pm. She's been told her labs are normal so many times she's started to question her own symptoms.

Paloma also serves:

• The newly diagnosed who want to start their treatment journey with a complete picture, not a partial one
• The self-advocates who've done their research and know they need a Free T4 test but can't get their doctor to order one
• The Hashimoto's patient managing an autoimmune condition that requires antibody monitoring, not just TSH tracking
• The frustrated prescription-hopper who's been switched between medications without understanding why their numbers look the way they do
• The post-partum or peri-menopausal woman whose thyroid function has shifted and whose symptoms are being dismissed as hormonal noise

What unites all of them is a history of not being heard — and a deep desire for a care team that takes their symptoms as seriously as their lab values.

Why This Moment Matters

Thyroid disease has always been common. What's changed is the expectation patients bring to healthcare. The generation now managing chronic conditions grew up with smartphones, access to PubMed, and communities of patients sharing notes on Reddit and Facebook groups. They know what Free T3 is. They've read the studies on T3/T4 combination therapy. They are arriving at appointments more informed than ever — and being dismissed anyway.

At the same time, the telehealth infrastructure built during and after the pandemic has made it genuinely possible to deliver specialist-quality care outside of a hospital system. Lab-at-home technology has matured. Asynchronous clinical workflows work. The barrier to accessing an endocrinologist used to be geographic and temporal — you had to live near a major medical center and wait three months for an appointment. Paloma removes both barriers entirely.

What Makes Paloma Different

Thyroid-adjacent services aren't new. Direct-to-consumer lab companies have offered thyroid panels for years. Telehealth platforms have listed endocrinology as a specialty. What makes Paloma distinct is the integration: testing, specialist care, and longitudinal monitoring built as a single, coherent system.

Most patients who order a thyroid panel from a generic lab company receive a PDF of numbers with no clinical context. Most telehealth appointments for thyroid conditions are one-time events — a prescription renewal, a quick question answered. Paloma connects these touchpoints into a care relationship. The symptom tracker doesn't just log data; it informs the next consultation. The retest isn't an isolated event; it's part of a trend line that a clinician actually reviews.

There's also a philosophical differentiation that matters deeply to the patient community Paloma serves: symptom-first, not reference-range-first. Paloma's clinicians are trained to treat the patient, not the TSH number. This sounds obvious. In practice, in the current healthcare system, it's radical.

"No one should have to fight their doctor for a complete thyroid panel. No one should be told they're fine when they clearly aren't. Paloma exists because thyroid patients deserve care that's as persistent as their condition."

Built with AI, Built for Scale

Paloma was brought to life using Artha — an AI platform that takes a company concept from a single prompt to a fully operational business, complete with branding, product infrastructure, and go-to-market foundation. The speed at which Paloma moved from idea to launch reflects the same principle behind the product itself: when the problem is clear and the need is urgent, the infrastructure should get out of the way.

Building a healthcare company at speed without sacrificing clinical rigor is a challenge that AI-first tooling is uniquely suited to address. Artha's approach allowed Paloma to focus on what matters — the clinical model, the patient experience, the relationship between symptoms and care — rather than getting stuck in the operational overhead that buries most early-stage health companies.

What's Next for Paloma

The immediate roadmap is clear: expand access, deepen the care model, and build the dataset that makes every patient's experience better over time. Thyroid care is a condition where longitudinal data is extraordinarily valuable — the patterns in how TSH, Free T3, and symptoms co-evolve over months and years are exactly the kind of signal that AI-assisted clinical decision support can learn from.

Longer term, Paloma sits at the center of a broader opportunity in autoimmune and endocrine care — conditions that share Hashimoto's thyroiditis's hallmarks of being common, chronic, underfunded in research, and poorly served by the seven-minute appointment model. A care infrastructure built to serve thyroid patients well is a care infrastructure that could serve lupus patients, rheumatoid arthritis patients, adrenal dysfunction patients — anyone whose condition requires continuous attention rather than episodic intervention.

For now, the mission is singular and urgent: make it so that no thyroid patient in America has to hear "your labs are normal" ever again when they clearly aren't.

Build Your Own Company on Artha

Paloma is proof that a focused, well-defined problem — combined with the right infrastructure — can become a company that genuinely changes how patients experience their care. The thyroid space has needed this for decades. It took a clear vision and a platform that could turn that vision into a product fast enough to matter.

If you have a problem worth solving — in healthcare, fintech, education, enterprise software, or anywhere else — Artha can help you build the company around it. One prompt. A real company. Launch-ready infrastructure, branding, and product foundation — built by AI, shaped by you.

Start building on Artha →